These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
39 related articles for article (PubMed ID: 36204657)
1. Phenotypic screening models for rapid diagnosis of genetic variants and discovery of personalized therapeutics. Hopkins CE; Brock T; Caulfield TR; Bainbridge M Mol Aspects Med; 2023 Jun; 91():101153. PubMed ID: 36411139 [TBL] [Abstract][Full Text] [Related]
2. Progranulin mutations in ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Cruts M; Kumar-Singh S; Van Broeckhoven C Curr Alzheimer Res; 2006 Dec; 3(5):485-91. PubMed ID: 17168647 [TBL] [Abstract][Full Text] [Related]
3. [Clinical, pathological, and genetic characteristics of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in the MAPT and PGRN]. Tsuboi Y Brain Nerve; 2009 Nov; 61(11):1285-91. PubMed ID: 19938685 [TBL] [Abstract][Full Text] [Related]
4. The use of CRISPR to generate a whole-gene humanized Lins J; Hopkins CE; Brock T; Hart AC MicroPubl Biol; 2022; 2022():. PubMed ID: 36204657 [TBL] [Abstract][Full Text] [Related]
5. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America. Gatto EM; Allegri RF; Da Prat G; Chrem Mendez P; Hanna DS; Dorschner MO; Surace EI; Zabetian CP; Mata IF Neurobiol Aging; 2017 May; 53():195.e11-195.e17. PubMed ID: 28268100 [TBL] [Abstract][Full Text] [Related]
6. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations. Snowden JS; Adams J; Harris J; Thompson JC; Rollinson S; Richardson A; Jones M; Neary D; Mann DM; Pickering-Brown S Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):497-505. PubMed ID: 26473392 [TBL] [Abstract][Full Text] [Related]
7. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Pickering-Brown SM; Rollinson S; Du Plessis D; Morrison KE; Varma A; Richardson AM; Neary D; Snowden JS; Mann DM Brain; 2008 Mar; 131(Pt 3):721-31. PubMed ID: 18192287 [TBL] [Abstract][Full Text] [Related]
8. Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients. Guven G; Lohmann E; Bras J; Gibbs JR; Gurvit H; Bilgic B; Hanagasi H; Rizzu P; Heutink P; Emre M; Erginel-Unaltuna N; Just W; Hardy J; Singleton A; Guerreiro R PLoS One; 2016; 11(9):e0162592. PubMed ID: 27632209 [TBL] [Abstract][Full Text] [Related]
9. Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images. Whitwell JL; Boeve BF; Weigand SD; Senjem ML; Gunter JL; Baker MC; DeJesus-Hernandez M; Knopman DS; Wszolek ZK; Petersen RC; Rademakers R; Jack CR; Josephs KA Eur J Neurol; 2015 May; 22(5):745-52. PubMed ID: 25683866 [TBL] [Abstract][Full Text] [Related]
10. Single copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration. Baskoylu SN; Yersak J; O'Hern P; Grosser S; Simon J; Kim S; Schuch K; Dimitriadi M; Yanagi KS; Lins J; Hart AC PLoS Genet; 2018 Oct; 14(10):e1007682. PubMed ID: 30296255 [TBL] [Abstract][Full Text] [Related]
11. Precision genome editing using CRISPR-Cas9 and linear repair templates in C. elegans. Paix A; Folkmann A; Seydoux G Methods; 2017 May; 121-122():86-93. PubMed ID: 28392263 [TBL] [Abstract][Full Text] [Related]
12. Rapid and precise engineering of the Caenorhabditis elegans genome with lethal mutation co-conversion and inactivation of NHEJ repair. Ward JD Genetics; 2015 Feb; 199(2):363-77. PubMed ID: 25491644 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous expression of multiple proteins under a single promoter in Caenorhabditis elegans via a versatile 2A-based toolkit. Ahier A; Jarriault S Genetics; 2014 Mar; 196(3):605-13. PubMed ID: 24361941 [TBL] [Abstract][Full Text] [Related]
14. Improved Mos1-mediated transgenesis in C. elegans. Frøkjær-Jensen C; Davis MW; Ailion M; Jorgensen EM Nat Methods; 2012 Jan; 9(2):117-8. PubMed ID: 22290181 [No Abstract] [Full Text] [Related]
15. Codon adaptation-based control of protein expression in C. elegans. Redemann S; Schloissnig S; Ernst S; Pozniakowsky A; Ayloo S; Hyman AA; Bringmann H Nat Methods; 2011 Mar; 8(3):250-2. PubMed ID: 21278743 [TBL] [Abstract][Full Text] [Related]